Candesartan Effect in Second Stage Arterial Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Stage II Hypertension
Interventions
DRUG

Candesartan Cilexetil

Candesartan Cilexetil 16 mg oral

DRUG

Hydrochlorothiazide

Hydrochlorothiazide 12.5 mg

DRUG

Candesartan Cilexetil

Candesartan Cilexetil 32 mg oral

Trial Locations (1)

Unknown

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY